The impact of treated XXXX within one month before living donor liver transplantation in adults.

@entity1 @entity1244 @entity8 @entity55 @entity298 @entity2348 @entity733 @entity3851 @entity293 @entity2259 @entity255
BACKGROUND: The impact of treated preoperative @entity2348 on the outcome of living-donor liver transplantation (LDLT) is not well defined. The aim of this study was to determine the frequency of pre-transplant @entity2348 within one month before LDLT and their impact on the post-transplant morbidity and mortality. MATERIAL AND METHODS: We retrospectively reviewed the records of 50 adult LDLT recipients between January 2009 and October 2011. @entity1 were divided into two groups based on whether they had episodes of @entity2348 within one month before LDLT. RESULTS: There were 20 @entity1 who required antimicrobial therapy for pre-transplant infections. The pre-transplant infections comprised @entity293 (35%), @entity255 (10%), @entity55 (10%), @entity2259 (5%), spontaneous @entity298 (5%), acute @entity1244 (5%), @entity733 (5%), and empirical treatment (25%). @entity1 with pre-transplant infections had higher @entity1 -Pugh scores [median, 11 vs. 9.5, P<0.05] and model for @entity3851 scores [median, 17.5 vs. 14, P<0.05] compared with the other @entity1 . There were no correlations between the pathogens involved in the pre-transplant infections and those involved in @entity8 . The incidence of @entity8 was higher in the pre-transplant infection group within one week after LDLT, but was almost the same within one month after LDLT. The one-year survival rates were not significantly different between the groups. CONCLUSIONS: Although pre-transplant infections are associated with a high risk of postoperative @entity2348 shortly after LDLT, they did not affect the short-term outcome when they had been appropriately treated before transplantation.
